Practical Guidance on Clinical Management of Belantamab Mafodotin-Associated Ocular Events.

Saved in:
Bibliographic Details
Title: Practical Guidance on Clinical Management of Belantamab Mafodotin-Associated Ocular Events.
Authors: Terpos E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Trudel S; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Mateos MV; Institute of Cancer Molecular and Cellular Biology, University Hospital of Salamanca/Institute of Biomedical Research of Salamanca, Salamanca University, Salamanca, Spain., Alejandre N; Department of Ophthalmology, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Colby K; Department of Ophthalmology, New York University Grossman School of Medicine, New York, New York, USA., Dimopoulos MA; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.; Department of Medicine, Korea University, Seoul, South Korea., Esposti SD; Moorfields Eye Hospital NHS Foundation Trust, London, UK., Farooq AV; Department of Ophthalmology and Visual Science, University of Chicago Medical Center, Chicago, Illinois, USA., Gavriatopoulou M; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Gay F; Division of Hematology, University of Turin, Azienda Ospedaliero-Universitaria Città Della Salute e Della Scienza di Torino, Turin, Italy., Hungria V; Clínica São Germano, São Paulo, Brazil., Kortüm KM; Department of Internal Medicine 2, University Hospital of Würzburg, Würzburg, Germany., Leleu X; Service D'hématologie et Thérapie Cellulaire, Hôpital La Milétrie, and Centre D'investigation Clinique INSERM 1402, Poitiers University Hospital, Poitiers, France., Lonial S; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA., Quach H; St. Vincent's Hospital Melbourne, University of Melbourne, Melbourne, Victoria, Australia., Qiu L; National Clinical Research Center for Blood Diseases, State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (PUMC), Tianjin, China., Ramasamy K; Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK; Oxford Translational Myeloma Centre, NDORMS, University of Oxford, Oxford, UK., Suzuki K; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan., Weisel KC; University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Richardson P; Jerome Lipper Multiple Myeloma Center, Division of Hematologic Malignancies, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
Source: American journal of hematology [Am J Hematol] 2025 Oct; Vol. 100 (10), pp. 1839-1850. Date of Electronic Publication: 2025 Jul 28.
Publication Type: Journal Article; Systematic Review; Practice Guideline; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1096-8652
DOI:10.1002/ajh.70015